1.One case of neck multiple schwannoma and merge meningioma.
Xian JIANG ; Shangjie BAI ; Yuanzhe JIN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(21):1219-1220
UNLABELLED:
Patients with cervical painless mass for 3 months with swallowing not feeling a week for the chief complaint.
PHYSICAL EXAMINATION
top right sternocleidomastoid before hitting a 7.0 by 3.0 cm size, lower limb reached 2.0 cm x 1.8 cm, the size of the mass on the left side of the supraclavicular reached 3.0 cm x 2.5 cm of the size of the mass, the three homogeneous medium hard, focally border and clear, the activity can be puncture cytological examination in return for: left supraclavicular see more protein and blood samples and a small amount of sample are arranged heap of fiber cells. Nuclear magnetic resonance (NMR): on the right side of the neck, with three at the left supraclavicular neoplasm, between 2.5-5.5 cm in size, high in T2, T1 low mixed signals, lesion boundaries clear.
Clavicle
;
Deglutition Disorders
;
etiology
;
Head and Neck Neoplasms
;
complications
;
pathology
;
Humans
;
Magnetic Resonance Imaging
;
Meningeal Neoplasms
;
pathology
;
Meningioma
;
pathology
;
Neck
;
Neurilemmoma
;
complications
;
pathology
;
Sensation Disorders
;
etiology
;
Tumor Burden
2.Effects of Yupingfeng Granules on Immune Function and Related Indexes of Children with Allergic Rhinitis Complicated with Bronchial Asthma
Shangjie BAI ; Sha LIANG ; Xiaojun LU
China Pharmacy 2018;29(4):530-533
OBJECTIVE: To investigate the effects of Yupingfeng granules on immune function and related indexes of children with allergic rhinitis (AR) complicated with bronchial asthma (BA). METHODS: Clinical information of 101 children with AR complicated with BA during Feb. 2014-Sept. 2017 were analyzed retrospectively, and they were divided into control group (47 cases) and observation group (54 cases) according to treatment plan. Control group was given Salmeterol xinafoate and fluticasone propionate powder for inhalation through mouth, one inhalation, twice a day+Mometasone furoate nasal spray 50 μg each nostril. Observation group was additionally given Yupingfeng granules 5 g orally, 3 times a day, for consecutive 2 weeks, drug withdrawal at 2 weeks interval, recycled 3 times. Both groups received treatment for consecutive 3 months. Clinical symptom and sign scores, the levels of T-lymphocyte subgroup (CD4+, CD8+, CD4+/CD8+), IL-4, IFN-γ and IgE before and after treatment, the occurrence of ADR were observed in 2 groups. RESULTS: Before treatment, there was no statistical significance in clinical symptom and sign scores, levels of T-lymphocyte subgroup, serum levels of IL-4, IFN-γ or IgE between 2 groups (P>0. 05). After treatment, clinical symptom and sign scores, CD4+, CD4+/CD8+, serum levels of IL-4 and IgE in 2 groups were all significantly lower than before treatment; observation group was significantly lower than control group. CD8+ and serum levels of IFN-y in 2 groups after treatment were significantly higher than before treatment; observation group was significantly higher than control group, with statistical significance (P<0. 05). There was no statistical significance in the incidence of ADR between 2 groups (P>0. 05). CONCLUSIONS: Yupingfeng granules can effectively improve immune function of children with AR complicated with BA, and relieve clinical symptom without increasing the occurrence of ADR.
3. A study on the quality of life and mental health of sinusitis patients with olfactory disorders
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2020;34(2):149-152
Objective:
The aim of this study is to investigate the incidence of dysosmia in patients with and without nasal polyps, and the impact of dysosmia on the quality of life and mental health in patients with Sinusitis.
Method:
A total of 105 randomly selected patients with Sinusitis were divided into two groups based on the results of the Sniffin's Sticks olfactory examination: The dysosmia group and the non dysosmia group, the quality of life (Qol) of olfaction quality of life scale and SCL-90 symptom checklist-90(SCL-90) were scored respectively.
Result:
The incidence of olfactory disorders in chronic sinusitis patients with nasal polyps was significantly higher than those without nasal polyps(χ²=37.133, P<0.001). The quality of life score of the olfactory disturbance scale the quality of life score of the olfactory disturbance group(26.5±5.9) was significantly higher than that of the non olfactory disturbance group(11.76±3.58)(t=14.30, P<0.0001). Life quality score(30.2±4.9) of female patients with olfactory dysfunction was significantly higher than that of male patients(22.3±4.0)(P<0.001), The score of SCL-90 of chronic sinusitis patients with olfactory dysfunction(n=64) is 6.6(6.0-8.0), while the score of SCL-90 of chronic sinusitis patients without olfactory dysfunction(n=41) is 7.0(6.2-7.6), and there was no significant difference between the two groups(P>0.05).
Conclusion
The risk of dysosmia in patients with Sinusitis polyps was significantly higher than that in patients without nasal polyps, and the quality of life in patients with Sinusitis was significantly lower than that in patients without sinusitis, women also had a greater impact on their quality of life than men, and Sinusitis patients with dysosmia had no significant impact on their mental health.
4.A study on the quality of life and mental health of sinusitis patients with olfactory disorders.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2020;34(2):149-152
The aim of this study is to investigate the incidence of dysosmia in patients with and without nasal polyps, and the impact of dysosmia on the quality of life and mental health in patients with Sinusitis. A total of 105 randomly selected patients with Sinusitis were divided into two groups based on the results of the Sniffin's Sticks olfactory examination: The dysosmia group and the non dysosmia group, the quality of life (Qol) of olfaction quality of life scale and SCL-90 symptom checklist-90(SCL-90) were scored respectively. The incidence of olfactory disorders in chronic sinusitis patients with nasal polyps was significantly higher than those without nasal polyps(χ²=37.133, <0.001). The quality of life score of the olfactory disturbance scale the quality of life score of the olfactory disturbance group(26.5±5.9) was significantly higher than that of the non olfactory disturbance group(11.76±3.58)(=14.30, <0.0001). Life quality score(30.2±4.9) of female patients with olfactory dysfunction was significantly higher than that of male patients(22.3±4.0)(<0.001), The score of SCL-90 of chronic sinusitis patients with olfactory dysfunction(=64) is 6.6(6.0-8.0), while the score of SCL-90 of chronic sinusitis patients without olfactory dysfunction(=41) is 7.0(6.2-7.6), and there was no significant difference between the two groups(>0.05). The risk of dysosmia in patients with Sinusitis polyps was significantly higher than that in patients without nasal polyps, and the quality of life in patients with Sinusitis was significantly lower than that in patients without sinusitis, women also had a greater impact on their quality of life than men, and Sinusitis patients with dysosmia had no significant impact on their mental health.